These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 8198985
1. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy. Twelves CJ, Porter DA, Lowry M, Dobbs NA, Graves PE, Smith MA, Rubens RD, Richards MA. Br J Cancer; 1994 Jun; 69(6):1151-6. PubMed ID: 8198985 [Abstract] [Full Text] [Related]
2. Phosphorus-31 metabolism of human breast--an in vivo magnetic resonance spectroscopic study at 1.5 Tesla. Twelves CJ, Lowry M, Porter DA, Dobbs NA, Graves PE, Smith MA, Richards MA. Br J Radiol; 1994 Jan; 67(793):36-45. PubMed ID: 8298873 [Abstract] [Full Text] [Related]
6. Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study. Kalra R, Wade KE, Hands L, Styles P, Camplejohn R, Greenall M, Adams GE, Harris AL, Radda GK. Br J Cancer; 1993 May; 67(5):1145-53. PubMed ID: 8494715 [Abstract] [Full Text] [Related]
7. 31P NMR study of cisplatin- and doxorubicin-induced changes in tumour metabolism in rats with a cisplatin-sensitive or -resistant immunocytoma. Sijens PE, van Echteld CJ, van Rijssel RH, Lagendijk JJ, Neijt JP, de Jong WH, van der Minnen AC, de Groot G, Seijkens D. NMR Biomed; 1990 Jun; 3(3):124-31. PubMed ID: 2386659 [Abstract] [Full Text] [Related]
10. Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphoma. Bryant DJ, Bydder GM, Case HA, Collins AG, Cox IJ, Makepeace A, Pennock JM. J Comput Assist Tomogr; 1988 Jun; 12(5):770-4. PubMed ID: 3170838 [Abstract] [Full Text] [Related]
12. 31P-magnetic resonance spectroscopy (31P-MRS) of human allografts after renal transplantation. Klemm A, Rzanny R, Fünfstück R, Werner W, Schubert J, Kaiser WA, Stein G. Nephrol Dial Transplant; 1998 Dec; 13(12):3147-52. PubMed ID: 9870480 [Abstract] [Full Text] [Related]
13. Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors. Park JM, Park JH. Korean J Radiol; 2001 Dec; 2(2):80-6. PubMed ID: 11752975 [Abstract] [Full Text] [Related]
14. Clinical magnetic resonance spectroscopy of human breast disease. Merchant TE, Thelissen GR, de Graaf PW, Den Otter W, Glonek T. Invest Radiol; 1991 Dec; 26(12):1053-9. PubMed ID: 1765437 [Abstract] [Full Text] [Related]
15. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. Jagannathan NR, Singh M, Govindaraju V, Raghunathan P, Coshic O, Julka PK, Rath GK. NMR Biomed; 1998 Nov; 11(8):414-22. PubMed ID: 10221584 [Abstract] [Full Text] [Related]
17. Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study. Patel N, Forton DM, Coutts GA, Thomas HC, Taylor-Robinson SD. Metab Brain Dis; 2000 Sep; 15(3):223-40. PubMed ID: 11206591 [Abstract] [Full Text] [Related]
19. Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. Piccart MJ, Di Leo A, Beauduin M, Vindevoghel A, Michel J, Focan C, Tagnon A, Ries F, Gobert P, Finet C, Closon-Dejardin MT, Dufrane JP, Kerger J, Liebens F, Beauvois S, Bartholomeus S, Dolci S, Lobelle JP, Paesmans M, Nogaret JM. J Clin Oncol; 2001 Jun 15; 19(12):3103-10. PubMed ID: 11408507 [Abstract] [Full Text] [Related]